TY - JOUR
T1 - Adiposity trajectory and its associations with plasma adipokine levels in children and adolescents - A prospective cohort study
AU - Li, Shenghui
AU - Liu, Rong
AU - Arguelles, Lester
AU - Wang, Guoying
AU - Zhang, Jun
AU - Shen, Xiaoming
AU - Wang, Xiaobin
N1 - Funding Information:
The twin study was supported in part by grant R01 HD049059 from the National Institute of Child Health and Human Development; grant R01HL086461 from the National Heart, Lung, and Blood Institute; and grant R01 AG032227 from the National Institute of Aging. Drs. Shenghui Li, Jun Zhang, and Xiaoming Shen were supported by the National Natural Science Foundation of China (81072314), Innovation Program of Shanghai Municipal Education Commission (13YZ034), 2012 Shanghai public health academic leader project (GWDTR201222), Shanghai Jiao Tong University medicine and engineering cross fund project (YG2013MS13), and National Undergraduates Innovating Experimentation Project (2012033).
Publisher Copyright:
© 2015 The Obesity Society.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Objective This study aimed to examine the associations of longitudinal adiposity measures with two adipokines, leptin and adiponectin, and their ratio in children and adolescents. Methods A total of 953 children and adolescents participated in a 6-year longitudinal study. Body mass index (BMI), percentage body fat (%BF), and fat mass index (FMI) were used to assess adiposity status. Results After adjusting for possible confounders, our regression models revealed that BMI, %BF, and FMI, in both the baseline and follow-up surveys were independently associated with a higher level of leptin and the leptin/adiponectin ratio at the follow-up survey, whereas the significant association with adiponectin only partly existed in adiposity measures at the follow-up visit. Moreover, the longitudinal change in adiposity measures was found to be a significant predictor for follow-up plasma adipokine levels. Compared with the low→low group, the medium→medium group, up-trend group, and high→high group all showed a significantly increased level of leptin and leptin/adiponectin ratio. The up-trend group and high→high group also had significantly decreased adiponectin levels. Conclusions These findings highlight the importance of adiposity surveillance and the utility of adipokines as biomarkers for adverse metabolic consequences of childhood adiposity.
AB - Objective This study aimed to examine the associations of longitudinal adiposity measures with two adipokines, leptin and adiponectin, and their ratio in children and adolescents. Methods A total of 953 children and adolescents participated in a 6-year longitudinal study. Body mass index (BMI), percentage body fat (%BF), and fat mass index (FMI) were used to assess adiposity status. Results After adjusting for possible confounders, our regression models revealed that BMI, %BF, and FMI, in both the baseline and follow-up surveys were independently associated with a higher level of leptin and the leptin/adiponectin ratio at the follow-up survey, whereas the significant association with adiponectin only partly existed in adiposity measures at the follow-up visit. Moreover, the longitudinal change in adiposity measures was found to be a significant predictor for follow-up plasma adipokine levels. Compared with the low→low group, the medium→medium group, up-trend group, and high→high group all showed a significantly increased level of leptin and leptin/adiponectin ratio. The up-trend group and high→high group also had significantly decreased adiponectin levels. Conclusions These findings highlight the importance of adiposity surveillance and the utility of adipokines as biomarkers for adverse metabolic consequences of childhood adiposity.
UR - http://www.scopus.com/inward/record.url?scp=84956589694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84956589694&partnerID=8YFLogxK
U2 - 10.1002/oby.21378
DO - 10.1002/oby.21378
M3 - Article
C2 - 26704698
AN - SCOPUS:84956589694
SN - 1930-7381
VL - 24
SP - 408
EP - 416
JO - Obesity
JF - Obesity
IS - 2
ER -